Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

HCA HEALTHCARE, INC.

(HCA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

HCA Healthcare : Citigroup Adjusts HCA Healthcare's Price Target to $274 from $268, Keeps Neutral Rating

10/25/2021 | 11:13am EST


ę MT Newswires 2021
All news about HCA HEALTHCARE, INC.
01/27HCA Healthcare On Pace for Largest Percent Decrease Since September 2020 -- Data Talk
DJ
01/27Health Care Stocks Higher Premarket Thursday
MT
01/27HCA HEALTHCARE : Company Increases Capital Spending, Authorizes Additional Share Repurchas..
PU
01/27HCA HEALTHCARE, INC. : Results of Operations and Financial Condition, Change in Directors ..
AQ
01/27HCA Healthcare Boosts Dividend by 17%, Adds $8 Billion to Buybacks
DJ
01/27HCA Healthcare Posts Higher Q4 Adjusted Earnings as Revenue Rises; Issues 2022 Targets
MT
01/27HCA : Q4 Earnings Snapshot
AQ
01/27HCA Healthcare Reports Fourth Quarter 2021 Results and Provides 2022 Guidance
BU
01/27Earnings Flash (HCA) HCA HEALTHCARE Reports Q4 Revenue $15.06B
MT
01/26HCA Healthcare Announces Plans to Build Five New Hospitals in Texas
BU
More news
Analyst Recommendations on HCA HEALTHCARE, INC.
More recommendations
Financials (USD)
Sales 2021 59 072 M - -
Net income 2021 6 462 M - -
Net Debt 2021 32 162 M - -
P/E ratio 2021 11,4x
Yield 2021 0,84%
Capitalization 71 178 M 71 178 M -
EV / Sales 2021 1,75x
EV / Sales 2022 1,67x
Nbr of Employees 235 000
Free-Float 77,1%
Chart HCA HEALTHCARE, INC.
Duration : Period :
HCA Healthcare, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HCA HEALTHCARE, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Last Close Price 228,85 $
Average target price 284,30 $
Spread / Average Target 24,2%
EPS Revisions
Managers and Directors
Samuel N. Hazen President, CEO, Chief Operating Officer & Director
William B. Rutherford CFO, Chief Accounting Officer & Executive VP
Thomas Fearn Frist Chairman
P. Martin Paslick VP-Information Technology & Services
Kathleen M. Whalen Senior VP, Chief Ethics & Compliance Officer
Sector and Competitors